Review Article

Cross-Talk between Gut Microbiota and Heart via the Routes of Metabolite and Immunity

Table 1

Summary of human trials studying the association between gut microbiome and cardiovascular disease.

StudyAimMethodOutcomeNumber

Koren et al. [8]To investigate the effect of oral or gut microbiota on the microbial composition of atherosclerotic plaquesqPCR, 16S rRNAThe abundances of Veillonella and Streptococcus in atherosclerotic plaques correlated with their abundance in the oral cavity30 adults: 15 CVD and 15 healthy
Hyvärinen et al. [9]To investigate the association between coronary artery disease and periodontal pathogensqPCRLevels of A. actinomycetemcomitans associated with increased risk for CAD179 CAD, 166 ACS, 119 healthy
Fak et al. [10]To elucidate the relationship between the oral microbiota composition and patients with asymptomatic and symptomatic atherosclerosis16S rRNAHigher relative abundance of the bacterial genus Anaeroglobus in symptomatic atherosclerosis27 symptomatic AS, 35 asymptomatic AS, 30 healthy controls
Karlsson et al. [11]To investigate whether the gut metagenome is associated with symptomatic atherosclerosisMEDUSAGenus Collinsella enriched in patients, Eubacterium and Roseburia enriched in controls12 symptomatic AS, 13 healthy controls
Jie et al. [12]To systematically examine the composition and functional capacity of the gut microbiome in relation to cardiovascular diseasesShotgun sequencingIncreased abundance of Enterobacteriaceae and Streptococcus spp. in patients218 CVD, 187 healthy controls
Luedde et al. [14]To systematically investigate specific changes of the intestinal microbiome in HF patients16S rRNADecreased diversity of the intestinal microbiome and downregulated key intestinal bacterial groups, such as Blautia, Collinsella, Erysipelotrichaceae, and uncl in HF patients20 HF, 20 controls
Kamo et al. [15]To investigate whether gut microbiota in HF is associated with aging16S rRNADiminished proportions of Bacteroidetes, larger quantities of Proteobacteria, and enriched Lactobacillus in older patients with HF12 HF patients younger than 60 years, 10 HF patients 60 years of age or older

CAD: coronary artery disease.